AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...
While most “Crossroads” podcasts focus on religion angles in major news stories, this week’s episode focused, you guessed it, on a short news “brief.” The problem is that we are talking about a brief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results